Abstract
Torsade de pointes (TdP) is associated with long QT (LQT) syndromes which can be precipitated by altering cardiac potassium currents e.g. IKr (LQT2) or the cardiac sodium current INa (LQT3). The aim of this study was to test the hypothesis that ATX-II will potentiate E-4031-induced TdP. Experiments were performed in pentobarbital-anaesthetized α1-adrenoceptor-stimulated male New Zealand White rabbits. Rabbits were given increasing doses of either the INa opener ATX-II (n=6), the IKr blocker E-4031 (n=6), or both drugs in combination (n=6).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
